Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Olaparib | PARP | Misc | 59.3998 | 0.7945 | 0.0408 | -0.0007 | 0.6167 | 350.419 | 0.98306 |
HCC1806 | Abemaciclib | CDK4/6 | Cell cycle | 0.59453 | -0.4440 | 0.3921 | 0.1035 | 0.6190 | 3.5069 | 0.96621 |
SK-BR-3 | Dasatinib | BCR/ABL | MAPK/nRTK | 3.6452 | 0.0810 | 0.0617 | 0.0233 | 5.0000 | 3.5272 | 0.98252 |
T47D | Olaparib | PARP | Misc | Inf | 0.5304 | 0.0302 | 0.0015 | 4.9632 | 3.5388 | 0.95841 |
SK-BR-3 | Olaparib | PARP | Misc | 12.0744 | 0.5653 | 0.0429 | 0.0174 | 1.0158 | 35.3887 | 0.93619 |
HCC1395 | Alpelisib | PI3Ka | PI3K/mTOR | 14.2707 | 0.6375 | 0.0319 | 0.0088 | 1.2066 | 35.4714 | 0.90001 |
MDA-MB-361 | Cediranib | VEGFR/cKIT | RTK | 2.2171 | -0.9803 | 0.2895 | 0.1040 | 2.2939 | 3.5791 | 0.96048 |
CAMA-1 | Ceritinib | ALK | RTK | 1.797 | -0.6988 | 0.2366 | 0.0972 | 1.5849 | 3.5941 | 0.99647 |
Hs 578T | Ceritinib | ALK | RTK | 0.96543 | -0.4356 | 0.3052 | 0.1254 | 0.8330 | 3.6097 | 0.98175 |
MDA-MB-134-VI | Cisplatin | Chemo | Chemotherapy | 10.3229 | 0.5019 | 0.0719 | -0.0064 | 0.7594 | 36.1235 | 0.92643 |
MDA-MB-361 | Cisplatin | Chemo | Chemotherapy | 2.6294 | -0.3498 | 0.1809 | 0.0253 | 2.1659 | 3.6196 | 0.98908 |
SUM1315MO2 | Cisplatin | Chemo | Chemotherapy | 1.275 | 0.2028 | 0.2961 | 0.0592 | 0.4798 | 3.6243 | 0.95111 |
HME1 | Cabozantinib | VEGFR2/MET | RTK | 3.2402 | -0.1052 | 0.1020 | 0.0260 | 2.6885 | 3.6278 | 0.98973 |
CAMA-1 | ABT-737 | Bcl2/XL | Misc | Inf | 0.8643 | 0.0008 | 0.0221 | 5.0000 | 3.6752 | 0.74188 |
BT-549 | Saracatinib | SRC | MAPK/nRTK | Inf | 0.5558 | 0.0348 | 0.0015 | 3.3790 | 3.6758 | 0.97565 |
HME1 | Ipatasertib | AKT | PI3K/mTOR | Inf | 0.6353 | 0.0365 | 0.0079 | 1.2722 | 3.6876 | 0.93611 |
MDA-MB-157 | Pictilisib | pan PI3K | PI3K/mTOR | 2.0533 | 0.1874 | 0.2583 | 0.0226 | 0.3801 | 36.9459 | 0.95358 |
HCC1937 | Taselisib | PI3Ka, g, d | PI3K/mTOR | 1.2267 | 0.1206 | 0.2771 | 0.0422 | 0.5159 | 3.7186 | 0.99159 |
MDA-MB-453 | Cediranib | VEGFR/cKIT | RTK | 2.7824 | -0.6894 | 0.1569 | 0.0768 | 3.0858 | 3.7659 | 0.99464 |
MDA-MB-134-VI | Ipatasertib | AKT | PI3K/mTOR | 8.0392 | 0.4925 | 0.0150 | 0.0096 | 4.9968 | 3.7717 | 0.94642 |
MCF7 | Neratinib | EGFR/HER2 | RTK | 1.2629 | 0.0582 | 0.1421 | 0.0220 | 1.0034 | 3.7746 | 0.97694 |
BT-549 | Olaparib | PARP | Misc | 11.948 | 0.5432 | 0.0657 | 0.0130 | 0.9548 | 37.7564 | 0.91931 |
T47D | A-1210477 | Mcl-1 | Misc | Inf | 0.5752 | 0.0227 | 0.0055 | 5.0000 | 3.7781 | 0.96287 |
HCC1143 | Olaparib | PARP | Misc | 8.8262 | 0.4562 | 0.0925 | 0.0158 | 0.7545 | 37.8573 | 0.98047 |
BT-20 | PF-4708671 | p70S6K | PI3K/mTOR | 15.1446 | 0.6601 | 0.0129 | 0.0102 | 1.1942 | 37.9666 | 0.89476 |